Concepedia

Mohammad Kamil Hussain

MK

Statistics

Publications

5

Citations

124

H-Index

5

Active since

2011

Affiliations

Central Drug Research Institute(Current)

Mohammad Kamil Hussain is an author at Central Drug Research Institute specializing in pharmacology, medicine, and molecular oncology.

Publications per year

2011–2016

5

Publications

5

Design and synthesis of ERα/ERβ selective coumarin and chromene derivatives as potential anti-breast cancer and anti-osteoporotic agents

Mohammad Kamil Hussain, Mohd. Imran Ansari, Nisha Yadav et al. · RSC Advances · 2014 · 68 citations

, , +14

The anti-proliferative effect of 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b) pyran is potentiated via induction of estrogen receptor beta and p21 in human endometrial adenocarcinoma cells

Iram Fatima, Ruchi Saxena, Geetika Kharkwal et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2013 · 18 citations

, , +8

Discovery of 3,4,6‐Triaryl‐2‐pyridones as Potential Anticancer Agents that Promote ROS‐Independent Mitochondrial‐Mediated Apoptosis in Human Breast Carcinoma Cells

Mohammad Imran Ansari, Ashutosh Arun, Mohammad Kamil Hussain et al. · ChemistrySelect · 2016 · 15 citations

, , +15

Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus

Vishal Chandra, Iram Fatima, Ruchi Saxena et al. · American Journal of Obstetrics and Gynecology · 2011 · 13 citations

, , +10

Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft

Ruchi Saxena, Iram Fatima, Vishal Chandra et al. · Steroids · 2013 · 10 citations

, , +13

1–5 of 5